Answers are grounded in this paper and cite their sources.
Clinical abnormalities attributable to peripheral neuropathy were common in childhood cancer survivors and persisted long term, with concurrent deficits in patient-reported outcomes. Both the type of neurotoxic agent and a targeted clinical neurological assessment are important considerations when screening survivors for long-term neuropathy. Further development of peripheral neuropathy-specific pediatric assessment tools will aid research into neuroprotective and rehabilitative strategies.
No takes yet. Share an insight, caveat, or question.
Kandula et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: